abcb1 rabbit igg polyclonal antibody (Proteintech)
Proteintech is a verified supplier 
96
Structured Review
Proteintech
abcb1 rabbit igg polyclonal antibody
Abcb1 Rabbit Igg Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 186 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/abcb1+rabbit+igg+polyclonal+antibody/P+glycoprotein+Antibody/pm38885537-115-12-18
Average 96 stars, based on 186 article reviews
Abcb1 Rabbit Igg Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 186 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/abcb1+rabbit+igg+polyclonal+antibody/P+glycoprotein+Antibody/pm38885537-115-12-18
Average 96 stars, based on 186 article reviews
abcb1 rabbit igg polyclonal antibody - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Staining:Article Title: Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration. Article Snippet: Aims: Lansoprazole is one of the many proton pump inhibitors (PPIs) that acts more strongly with ABCB1 and ABCG2.. The present study is to investigate the potential of lansoprazole on reversal of ABCB1/G2-mediated MDR in cancer, in vitro and in vivo.. Methods: Reversal studies and combination evaluation were conducted to determine the synergistic anti-MDR effects on lansoprazole. Recombinant:Article Title: Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration. Article Snippet: Aims: Lansoprazole is one of the many proton pump inhibitors (PPIs) that acts more strongly with ABCB1 and ABCG2.. The present study is to investigate the potential of lansoprazole on reversal of ABCB1/G2-mediated MDR in cancer, in vitro and in vivo.. Methods: Reversal studies and combination evaluation were conducted to determine the synergistic anti-MDR effects on lansoprazole. Blocking Assay:Article Title: Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration. Article Snippet: Aims: Lansoprazole is one of the many proton pump inhibitors (PPIs) that acts more strongly with ABCB1 and ABCG2.. The present study is to investigate the potential of lansoprazole on reversal of ABCB1/G2-mediated MDR in cancer, in vitro and in vivo.. Methods: Reversal studies and combination evaluation were conducted to determine the synergistic anti-MDR effects on lansoprazole. Immunofluorescence:Article Title: Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration. Article Snippet: Aims: Lansoprazole is one of the many proton pump inhibitors (PPIs) that acts more strongly with ABCB1 and ABCG2.. The present study is to investigate the potential of lansoprazole on reversal of ABCB1/G2-mediated MDR in cancer, in vitro and in vivo.. Methods: Reversal studies and combination evaluation were conducted to determine the synergistic anti-MDR effects on lansoprazole. Incubation:Article Title: Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration. Article Snippet: Aims: Lansoprazole is one of the many proton pump inhibitors (PPIs) that acts more strongly with ABCB1 and ABCG2.. The present study is to investigate the potential of lansoprazole on reversal of ABCB1/G2-mediated MDR in cancer, in vitro and in vivo.. Methods: Reversal studies and combination evaluation were conducted to determine the synergistic anti-MDR effects on lansoprazole. |